beta-Lactamase Inhibitors
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"beta-Lactamase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D065093
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D27.505.519.389.400 D27.505.954.122.085.516 
						 | 
					
					
						| Concept/Terms | 
						
							beta-Lactamase Inhibitors- beta-Lactamase Inhibitors
 - Inhibitors, beta-Lactamase
 - beta Lactamase Inhibitors
 - Inhibitors, beta Lactamase
 - Lactamase Inhibitors, beta
 - beta Lactamase Antagonists
 - Antagonists, beta Lactamase
 - Lactamase Antagonists, beta
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "beta-Lactamase Inhibitors".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "beta-Lactamase Inhibitors".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "beta-Lactamase Inhibitors" by people in this website by year, and whether "beta-Lactamase Inhibitors" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1996 | 1 | 0 | 1 | 
| 2000 | 1 | 0 | 1 | 
| 2014 | 1 | 0 | 1 | 
| 2016 | 1 | 0 | 1 | 
| 2017 | 1 | 0 | 1 | 
| 2018 | 0 | 1 | 1 | 
| 2020 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "beta-Lactamase Inhibitors" by people in Profiles.
						
					
								- 
								
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
															
								 
							
								- 
								
Siderophore Conjugates of Daptomycin are Potent Inhibitors of Carbapenem Resistant Strains of Acinetobacter baumannii. ACS Infect Dis. 2018 10 12; 4(10):1529-1535.
															
								 
							
								- 
								
Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation. Antimicrob Agents Chemother. 2017 12; 61(12).
															
								 
							
								- 
								
Amoxicillin-Clavulanate-Induced Liver Injury. Dig Dis Sci. 2016 08; 61(8):2406-2416.
															
								 
							
								- 
								
Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria. J Am Chem Soc. 2014 Apr 02; 136(13):4873-6.
															
								 
							
								- 
								
Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,). Biochemistry. 2000 May 09; 39(18):5312-21.
															
								 
							
								- 
								
Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase. Nat Struct Biol. 1996 Aug; 3(8):688-95.
															
								 
							
								- 
								
Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother. 1976 Jul; 10(1):106-11.